About Eckuity
Eckuity is a venture capital firm founded in 2021. It is primarily based out of New York City, United States. As of Jul 2025, Eckuity has invested in 6 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series C round of Kardium A lot of funds co-invest with Eckuity, with names like Janus Henderson Investors sharing a substantial percentage of its portfolio. Eckuity has team of 15 people including 2 partners.Key Metrics
Eckuity's List of Top Investments
Eckuity has a portfolio of 6 companies. Their most notable investmentis in Mobius BiomedicalTheir portfolio spans across United States, Canada and United Kingdom. They have invested in Life Sciences, Enterprise Applications, HealthTech and 1 other sectors, across stages such as Seed, Series B and 2 more. Here is the list of top investments by Eckuity:1. Kardium
Kardium is developing the Globe mapping and ablation system. It's an investigational medical device, used in the diagnosis and treatment of atrial fibrillation. It provides mapping, stimulation, and RF ablation of cardiac tissue.
Key facts about Kardium
- Founded Year: 2007
- Location: Burnaby (Canada)
- Stage: Series C
- Total Funding till date: $471M
- Employee Count: 695 as on Sep 30, 2026
- Investors: T. Rowe Price, Fidelity Investments and 10 Others
- Latest Funding Round: Series C, Jul 08, 2025, $*****
- Highlight: Editors' Pick
2. Avive
Developer of an automated external defibrillator. The company offers next-generation automated external defibrillators and software solutions to increase survival rates from sudden cardiac arrest.
Key facts about Avive
- Founded Year: 2017
- Location: Brisbane (United States)
- Annual Revenue: £0 - £1M as on Apr 30, 2023
- Stage: Series B
- Total Funding till date: $111M
- Employee Count: 153 as on Aug 31, 2026
- Investors: Questa Capital, RC Capital and 12 Others
- Latest Funding Round: Series B, Feb 01, 2024, $*****
- Highlight: Editors' Pick
3. Vivance
Do Not Publish request by OD
Key facts about Vivance
- Founded Year: 2010
- Location: Magog (Canada)
- Stage: Series B
- Total Funding till date: $71.2M
- Employee Count: 143 as on Sep 30, 2026
- Investors: SEEDS Capital, Advanced MedTech and 4 Others
- Latest Funding Round: Series B, Sep 13, 2023, $*****
- Highlight: Editors' Pick
Developer of software for data analytics and insights. The platform is offering AI and ML-based applications which enables users to filter and analyze data sets in real-time to provide results, predictions, or insights based on the analysis for precision medicine. It offers features such as data management, design workflows, data visualization, and many more.
Key facts about Sonrai Analytics
- Founded Year: 2018
- Location: Belfast (United Kingdom)
- Stage: Seed
- Total Funding till date: $3.56M
- Employee Count: 33 as on Sep 30, 2026
- Investors: Molten Ventures, Forward Partners and 25 Others
- Latest Funding Round: Seed, Sep 04, 2025, $*****
- Highlight: Editors' Pick
Enquyst Technologies is a biotechnology company that is revolutionizing the way biological drugs are manufactured. The company is developing novel, next-generation bioprocessing technology solutions to improve the efficiency and scalability of biologic production. Enquyst's patented technology is designed to simplify the downstream purification process, enabling the production of high-purity biologics at a lower cost.
Key facts about Enquyst Technologies Inc
- Founded Year: 2017
- Location: Amherst (United States)
- Stage: Series A
- Total Funding till date: $6M
- Employee Count: 12 as on Sep 30, 2026
- Investors: Eckuity
- Latest Funding Round: Series A, Jun 04, 2025, $*****
Eckuity's Year-on-Year Investment Trends
Eckuity has invested in 6 companies over the last 4 years, with an average of 1 new investment annually in the last 3 years. In 2025, it made 2 investments. Its most recent first time investment was in Kardium.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 2 | 0 | 2 |
2024 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
2022 | 2 | 0 | 2 |
Eckuity's Investments by Stage
Eckuity has made 2 investments in Seed stage, 2 investments in Series B stage with an average round size of $38.4M, 1 investment in Series A stage with an average round size of $6M and 1 investment in Series C stage with an average round size of $250M.Stage of entry | No. of Investments |
|---|---|
Seed | 2 |
Series B | 2 |
Series A | 1 |
Series C | 1 |
Note: We have considered here, only first round of investments
Eckuity's Investments by Sector
Eckuity has a diverse portfolio, with companies operating in the Life Sciences, Healthcare, Enterprise Applications and HealthTech. Notably, it has invested in 4 Tech companies, 3 Enterprise (B2B) companies, 3 Tech hardware companies and at least 2 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 4 |
Healthcare | 2 |
Enterprise Applications | 1 |
HealthTech | 1 |
Note: We have considered here, only first round of investments
Eckuity's Investments by Geography
Eckuity has made most investments in United States (3), followed by Canada where it has made 2 investments.Country | No. of Investments |
|---|---|
United States | 3 |
Canada | 2 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
Eckuity's recent investments
Eckuity has not made any investment in 2026 so far.Here are the most recent investments by Eckuity:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jul 08, 2025 | Canada | Series C | 8703 | ||
Jun 04, 2025 | United States | Series A | 3619 | - | |
Feb 01, 2024 | United States | Series B | 2654 | [+3] | |
Sep 13, 2023 | Canada | Series B | 3951 | ||
Nov 11, 2022 | United Kingdom | Seed | 6828 | - |
Team profile of Eckuity
Eckuity has a team of 15 members including 2 Partners, 6 Venture Partners and 2 Principals located in United States, United Kingdom and 2 more locations. Eckuity's team sits on the board of 1 company.Here is a list of top team members in Eckuity:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | London | - | ||
Partner | New York City | - | ||
Venture Partner | San Francisco | - | - | |
Venture Partner | New York City | - | ||
Venture Partner | New York City | - | - | |
Venture Partner | France | - | - | |
Venture Partner | - | - | - | |
Venture Partner | Kettenhausen | - | - | |
Principal | New York City | - | - | |
Principal | London | - | - |
Co-investors of Eckuity
Over the past 4 years, 28 investors have co-invested in Eckuity's portfolio companies. This includes funds and angels.
- Invested before Eckuity: T. Rowe Price, Fidelity Investments and 18 others have invested in rounds before Eckuity. There is 1 company where T. Rowe Price has invested before Eckuity and 1 company where Fidelity Investments has invested before Eckuity.
- Top Co-investors of Eckuity: 7 investors entered a company along with Eckuity. These include investors like Janus Henderson Investors (1 company).
- Invested after Eckuity: Beach Equity (1 company) is the only investor which has invested in Eckuity's portfolio after their investments.
Recent News related to Eckuity
•
•
Kardium Secures $250M (CA$340M) to Launch Atrial Fibrillation Treatmentintelligence360•Jul 08, 2025•Eventide Asset Management, Eckuity, Qatar Investment Authority, Kardium
•
Huma Therapeutics Acquires Aluna, Inks Partnership with Eckuity Capital
HIT Consultant•May 16, 2025•Huma, Eckuity, Aluna
•
Cordillera: $10 Million Investment In Professional Triathletes OrganisationPulse 2.0•Mar 19, 2025•Cordillera Investment Partners, PTO, Divergent Investments, Warner Bros. Discovery and 1 other
•
Endeavor bags $132.5M series C, extending runway for clinical-stage fibrosis drugs through 2026Fierce Biotech•Apr 24, 2024•Endeavor Biomedicines, SymBiosis, Velocity Capital Management, Woodline Partners and 14 others
•
Avive Solutions Raises $56.5M FundingSilicon Valley Journals•Apr 18, 2024•Avive, Questa Capital, Laerdal Million Lives Fund, CHV and 2 others
•
AWAK Technologies takes in $20M for portable dialysis systemFierce Biotech•Sep 14, 2023•AWAK, X Ventures, Vickers Venture Partners, Eckuity and 5 others
•
•
Belfast’s Sonrai Analytics secures investment to accelerate US businessSilicon Republic•Nov 10, 2022•Sonrai Analytics, Eckuity
•
Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius BiomedicalBusiness Wire•Mar 28, 2022•Eckuity, Mobius Biomedical
